Nolato ABFRA:NBF +6.95%82 FCF Margin % is 9.55% as of Mar. 2026, which is 50% above its 10-year median of 6.38. GuruFocus rates FRA:NBF with a GF Score™ of 82/100 and a GF Value™ of €5.00 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Nolato AB ranks better than 78.16% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Nolato AB's Free Cash Flow for the
three
months ended in Mar. 2026 was €20.9 Mil. Nolato AB's Revenue for the
three
months ended in Mar. 2026 was €218.8 Mil. Therefore, Nolato AB's FCF Margin % for the quarter that ended in Mar. 2026 was 9.55%.
The historical rank and industry rank for Nolato AB's FCF Margin % or its related term are showing as below:
FRA:NBF'
s FCF Margin % Range Over the Past 10 Years
Min: -0.45 Med: 6.38 Max: 12.29
Current: 12.29
During the past 13 years, the highest FCF Margin % of Nolato AB was 12.29%. The lowest was -0.45%. And the median was 6.38%.
FRA:NBF's FCF Margin % is ranked better than 78.16% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs FRA:NBF: 12.29
Nolato AB FCF Margin % Related Terms
Nolato AB FCF Margin % Historical Data
* Premium members only.
The historical data trend for Nolato AB's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nolato AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nolato AB FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nolato AB's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Nolato AB's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nolato AB (FRA:NBF) has a FCF Margin % of 9.55% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Nolato AB and its competitors. This is 50% above median its historical median of 6.38. According to the industry distribution chart, Nolato AB ranks #178 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 21.8%.
Is Nolato AB's FCF Margin % too high?
Nolato AB's current FCF Margin % of 9.55% is 50% above median its 10-year median of 6.38. Based on the distribution chart, Nolato AB ranks #178 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Nolato AB has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nolato AB's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nolato AB ranks #178 out of 815 companies for FCF Margin %. This places Nolato AB in the top 22% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Nolato AB and its competitors. Nolato AB's current FCF Margin % is 9.55%, which is 50% above median its own 10-year median of 6.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nolato AB stock overvalued right now?
Based on GuruFocus' analysis, Nolato AB (FRA:NBF) is currently considered Modestly Undervalued. The stock's GF Value™ is €5.00, compared to a current price of €4.47 — trading 10.7% below its estimated fair value. The current FCF Margin % is 9.55%, which is 50% above median its 10-year median of 6.38. Nolato AB's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Nolato AB (FRA:NBF), the current FCF Margin % is 9.55% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nolato AB (FRA:NBF) Overvalued in 2026?
Based on GuruFocus' analysis, Nolato AB stock appears to be undervalued.
The current stock price of €4.47 is trading 10.7% below its estimated GF Value™ of €5.00.
GuruFocus considers Nolato AB to be Modestly Undervalued.
Key valuation signals for FRA:NBF:
FCF Margin %: 9.55% (50% above median its 10-year median of 6.38)
GF Value™: €5.00 vs. price of €4.47 (10.7% below fair value)
No single metric tells the full story. See the FRA:NBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nolato AB is a Swedish company that develops and manufactures plastic, silicone, and thermoplastic elastomer products. The firm's operations are organized into two segments: Medical Solutions and Engineered Solutions. The company generates the majority of its revenue from the Medical Solutions segment, which is engaged in the development and manufacture of complex product systems and components for medical devices, the pharmaceutical industry, and diagnostics. The Engineered Solutions design, development, industrialization, and manufacture of subsystems and ready-packaged products for a range of industries, including offerings within EMC and thermal solutions. Geographically, the firm generates key revenue from the Rest of Europe and the United States.
82GF Score
Get the complete analysis for FRA:NBF
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:NBF has been successfully added to your 
